Tom Gottfried Published in Bloomberg Tax

Featured in the Daily Tax Report, Gottfried suggests it’s not too soon for companies to engage in some analysis of its impact on their effective tax rate and to incorporate the possibility of its adoption into their long-term planning.

Chris Krapfl on Company Value Drivers in Business Observer

As seen in Business Observer, Chris Krapfl discusses how the ongoing assessment of a company’s value drivers is integral to success.

Best Practices for Private Fund Sponsors

As the demand for transparency rises for private investment funds, the spotlight is on valuation practices, which is essential for any fund manager to understand.

PJ Patel Discusses Pandemic Writedowns with Bloomberg

For some big impairments of 2020, the broader economic turmoil of the pandemic eclipsed and minimized news about the writedowns.

Solvency Opinions: Approving Leveraged Dividend Recapitalizations

Board members can demonstrate that they have fulfilled their fiduciary duties in dividend recapitalization transactions by obtaining opinions from third-party solvency opinion experts.

Birnbaum, Walling on Valuing Private Energy Debt and Equity in Private Funds CFO

As seen in the newest issue of Private Funds CFO, Jeff Birnbaum and Chris Walling discuss the implications of the pandemic for the sector.

John Czapla Featured in Sanne Group’s Connect November Issue

On track for recovery: Pandemic implications, not all doom or gloom.

Bloomberg Financial Accounting News Shares Mutarelli’s Post-Q3 Results

In the November issue, Bloomberg publishes Mutarelli’s third-quarter analysis results of valuations and impairment testing, including potential goodwill impairment.

Paul Balynsky Shares Views on Unicorn Valuations in COVID with AICPA Professional Insights

How are privately held unicorns’ valuations faring in the age of COVID?

Jason Mutarelli Published in Bloomberg Tax

Featured in the October issue, Mutarelli analyzes how to approach valuations and impairment testing when managing through the impacts of COVID.